An Open Label, Phase II Trial of Afatinib with Paclitaxel for the Neoadjuvant Treatment of Triple-Negative Breast Cancer and Research of Biomarkers of Activity and Efficacy of Afatinib (II)

Project title

評估Afatinib 合併太平洋紫杉醇用於三陰性乳癌之術前治療第II期臨床試驗的療效並尋求可預測Afatinib 有效性之生物標記(II)

Internal ID

MOST104-2325-B002-020

Principal Investigator

CHIUN-SHENG HUANG

Start Date

August 1, 2015

End Date

July 12, 2016

Partner Organizations

National Science and Technology Council